Position in INCY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$486,427
+$72,205 QoQ
Shares Held
4,291
-2.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#525
of 849 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Newman Dignan & Sheerar, Inc. holds $919,078 across 2 Biotechnology names. INCY ranks #1 (52.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
This page
|
4,291 | $486,427 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
871 | $432,651 |
All Filings in INCY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $486,427 | 4,291 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $414,222 | 4,401 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $434,686 | 4,401 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $412,600 | 4,865 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $331,306 | 4,865 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $286,825 | 4,737 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $360,683 | 5,222 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $331,954 | 5,022 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $269,274 | 4,442 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $239,103 | 4,197 | Shares | Sole | 2024-04-29 | |
| No filing history on record for this holder in this stock. | ||||||